Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

被引：0
|
作者：
Takashi Seto
Naoyuki Nogami
Nobuyuki Yamamoto
Shinji Atagi
Naoki Tashiro
Yoko Yoshimura
Yutaka Yabuki
Hideo Saka
机构：
[1] National Hospital Organization Kyushu Cancer Center,Department of Thoracic Oncology
[2] National Hospital Organization Shikoku Cancer Center,Department of Thoracic Oncology and Medicine
[3] Wakayama Medical University Hospital,Third Department of Internal Medicine
[4] National Hospital Organization Kinki-chuo Chest Medical Center,Department of Thoracic Oncology
[5] AstraZeneca K.K.,Medical Department
[6] National Hospital Organization Nagoya Medical Center,Department of Medical Oncology
来源：
Oncology and Therapy | 2018年 / 6卷 / 2期
关键词：
T790M; Epidermal growth factor receptor; Non-small-cell lung cancer; Osimertinib; Rebiopsy;
D O I：
10.1007/s40487-018-0064-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：203 / 215
页数：12
相关论文
共 50 条
  • [1] Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan
    Seto, Takashi
    Nogami, Naoyuki
    Yamamoto, Nobuyuki
    Atagi, Shinji
    Tashiro, Naoki
    Yoshimura, Yoko
    Yabuki, Yutaka
    Saka, Hideo
    ONCOLOGY AND THERAPY, 2018, 6 (02) : 203 - 215
  • [2] ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)
    Zhou, Q.
    Zhang, H. -L.
    Jiang, L. -Y.
    Shi, Y. -K.
    Chen, Y.
    Yu, J. -M.
    Zhou, C. -C.
    He, Y.
    Hu, Y. -P.
    Liang, Z. -A.
    Pan, Y. -Y.
    Zhuo, W. -L.
    Song, Y.
    Wu, G.
    Chen, G. -Y.
    Lu, Y.
    Zhang, C. -Y.
    Zhang, C. -Y.
    Zhang, Y. -P.
    Chen, Y.
    Lu, S.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S429 - S430
  • [3] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
    Imamura, Fumio
    Kimura, Madoka
    Yano, Yukihiro
    Mori, Masahide
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Ihara, Shouichi
    Komuta, Kiyoshi
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Kumagai, Toru
    FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546
  • [4] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [5] ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer
    de Marinis, Filippo
    Wu, Yi-Long
    de Castro Jr, Gilberto
    Chang, Gee-Chen
    Chen, Yuh-Min
    Cho, Byoung Chul
    Freitas, Helano C.
    Jiang, Liyan
    Kim, Sang-We
    Martin, Claudio
    Metro, Giulio
    Provencio, Mariano
    Vansteenkiste, Johan
    Vicente, David
    Zhou, Qing
    Miranda, Miguel F.
    Bakker, Nicolaas A.
    Rigas, James R.
    Cheema, Parneet K.
    FUTURE ONCOLOGY, 2019, 15 (26) : 3003 - 3014
  • [6] Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
    John, Thomas
    Bowden, Jeffrey J.
    Clarke, Stephen
    Fox, Stephen B.
    Garrett, Kerryn
    Horwood, Keith
    Karapetis, Christos S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 296 - 303
  • [7] Real-world analysis of the EGFR T790M mutation in plasma and tissue biopsy from advanced non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Chi Young
    Lee, Sang Hoon
    Kim, Eun Young
    Chang, Yoon Soo
    RESPIROLOGY, 2023, 28 : 99 - 100
  • [8] Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Pereira, Isabel
    Gaspar, Catia
    Pina, Marta
    Azevedo, Isabel
    Rodrigues, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [9] Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Peng, Da
    Shan, Dongfeng
    Dai, Chengcheng
    Li, Jie
    Wang, Zifan
    Huang, Ziyi
    Peng, Rui
    Zhao, Peng
    Ma, Xuezhen
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2033 - 2039
  • [10] Utility of T790M plasma and tissue biopsy testing in EGFR mutated non-small-cell lung cancer patients
    Preda, E.
    Shamash, J.
    Tarver, K.
    Ball, S.
    LUNG CANCER, 2020, 139 : S61 - S62
12345